Azenta Life Sciences (AZTA) stock price is up over 46% year-to-date. The company is set to sell its semiconductor automation business in the first half of 2022. CEO Dr. Stephen Schwartz weighs in on why Azenta Life Sciences (AZTA) is focusing on life sciences. Additionally, he provides the outlook for the company moving forward.
15 Dec 2021
Market On Close
15 Nov 2022
Market On Close
14 Oct 2022
Next Gen Investing
16 Sep 2022
Market On Close
09 Nov 2022
The Watch List
21 Nov 2022
Trading 360
02 Dec 2022